GPNMB and frontotemporal dementia: Intensity of GPNMB immunoreactivity was 6.5-fold higher (p < 0.01) in the frontal lobes of FTD-GRN brains compared to matched regions from the brains of cognitively normal controls (Fig. 7e, f, Fig. S7a–d).